首页>Journal of diabetes investigation>Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52weeks
作者单位：The Third Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan[1]Jikei University School of Medicine, Tokyo, Japan[2]Development Planning, Ono Pharmaceutical Co., Ltd, Osaka, Tokyo, Japan[3]MSD K. K, Tokyo, Japan[4]Merck Sharp and Dohme Corp., A subsidiary of Merck and Co., Inc, Whitehouse Station, NJ, United[5]Graduate School of Medicine, The University of Tokyo, Tokyo, Japan[6]
换一批
换一批
